BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34681211)

  • 1. The Specificity and Broad Multitarget Properties of Ligands for the Free Fatty Acid Receptors FFA3/GPR41 and FFA2/GPR43 and the Related Hydroxycarboxylic Acid Receptor HCA2/GPR109A.
    Bisenieks E; Vigante B; Petrovska R; Turovska B; Muhamadejev R; Soloduns V; Velena A; Pajuste K; Saso L; Klovins J; Duburs G; Mandrika I
    Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling of free fatty acid receptors 2 and 3 differs in colonic mucosa following selective agonism or coagonism by luminal propionate.
    Tough IR; Forbes S; Cox HM
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13454. PubMed ID: 30136343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3.
    Schmidt J; Smith NJ; Christiansen E; Tikhonova IG; Grundmann M; Hudson BD; Ward RJ; Drewke C; Milligan G; Kostenis E; Ulven T
    J Biol Chem; 2011 Mar; 286(12):10628-40. PubMed ID: 21220428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets.
    Ulven T
    Front Endocrinol (Lausanne); 2012; 3():111. PubMed ID: 23060857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids.
    Stoddart LA; Smith NJ; Jenkins L; Brown AJ; Milligan G
    J Biol Chem; 2008 Nov; 283(47):32913-24. PubMed ID: 18801738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut feelings in the islets: The role of the gut microbiome and the FFA2 and FFA3 receptors for short chain fatty acids on β-cell function and metabolic regulation.
    Teyani R; Moniri NH
    Br J Pharmacol; 2023 Dec; 180(24):3113-3129. PubMed ID: 37620991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FFA2 and FFA3 in Metabolic Regulation.
    Tang C; Offermanns S
    Handb Exp Pharmacol; 2017; 236():205-220. PubMed ID: 27757760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3.
    Hudson BD; Tikhonova IG; Pandey SK; Ulven T; Milligan G
    J Biol Chem; 2012 Nov; 287(49):41195-209. PubMed ID: 23066016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligands at the Free Fatty Acid Receptors 2/3 (GPR43/GPR41).
    Milligan G; Bolognini D; Sergeev E
    Handb Exp Pharmacol; 2017; 236():17-32. PubMed ID: 27757758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.
    Feingold KR; Moser A; Shigenaga JK; Grunfeld C
    J Lipid Res; 2014 Dec; 55(12):2501-8. PubMed ID: 25320346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2.
    Lee T; Schwandner R; Swaminath G; Weiszmann J; Cardozo M; Greenberg J; Jaeckel P; Ge H; Wang Y; Jiao X; Liu J; Kayser F; Tian H; Li Y
    Mol Pharmacol; 2008 Dec; 74(6):1599-609. PubMed ID: 18818303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-chain free-fatty acid G protein-coupled receptors in colon cancer.
    Moniri NH; Farah Q
    Biochem Pharmacol; 2021 Apr; 186():114483. PubMed ID: 33631190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty and hydroxycarboxylic acid receptors: The missing link of immune response and metabolism in cattle.
    Alarcon P; Manosalva C; Carretta MD; Hidalgo AI; Figueroa CD; Taubert A; Hermosilla C; Hidalgo MA; Burgos RA
    Vet Immunol Immunopathol; 2018 Jul; 201():77-87. PubMed ID: 29914687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Hydroxybutyrate modulates N-type calcium channels in rat sympathetic neurons by acting as an agonist for the G-protein-coupled receptor FFA3.
    Won YJ; Lu VB; Puhl HL; Ikeda SR
    J Neurosci; 2013 Dec; 33(49):19314-25. PubMed ID: 24305827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3.
    Milligan G; Stoddart LA; Smith NJ
    Br J Pharmacol; 2009 Sep; 158(1):146-53. PubMed ID: 19719777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pharmacology and Function of Receptors for Short-Chain Fatty Acids.
    Bolognini D; Tobin AB; Milligan G; Moss CE
    Mol Pharmacol; 2016 Mar; 89(3):388-98. PubMed ID: 26719580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-α-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells.
    Kobayashi M; Mikami D; Kimura H; Kamiyama K; Morikawa Y; Yokoi S; Kasuno K; Takahashi N; Taniguchi T; Iwano M
    Biochem Biophys Res Commun; 2017 Apr; 486(2):499-505. PubMed ID: 28322790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutively active GPR43 is crucial for proper leukocyte differentiation.
    Miyasato S; Iwata K; Mura R; Nakamura S; Yanagida K; Shindou H; Nagata Y; Kawahara M; Yamaguchi S; Aoki J; Inoue A; Nagamune T; Shimizu T; Nakamura M
    FASEB J; 2023 Jan; 37(1):e22676. PubMed ID: 36468834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-chain fatty acid mitigates adenine-induced chronic kidney disease via FFA2 and FFA3 pathways.
    Mikami D; Kobayashi M; Uwada J; Yazawa T; Kamiyama K; Nishimori K; Nishikawa Y; Nishikawa S; Yokoi S; Kimura H; Kimura I; Taniguchi T; Iwano M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158666. PubMed ID: 32061840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator.
    Smith NJ; Ward RJ; Stoddart LA; Hudson BD; Kostenis E; Ulven T; Morris JC; Tränkle C; Tikhonova IG; Adams DR; Milligan G
    Mol Pharmacol; 2011 Jul; 80(1):163-73. PubMed ID: 21498659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.